Zentiva to Acquire Sanofi’s Ankleshwar Manufacturing Facility in India

 Zentiva to Acquire Sanofi’s Ankleshwar Manufacturing Facility in India

Zentiva to Acquire Sanofi’s Ankleshwar Manufacturing Facility in India

Shots:

  • Sanofi signs a business transfer agreement with Zentiva to sell its manufacturing facility in Ankleshwar, India. In H1’19, Zentiva enhanced its network with the acquisition of Solacium in Romania and Creo in the UK
  • The focus of the acquisition is to expand Zentiva’s manufacturing footprint across the globe and help it to achieve operational excellence, enhance productivity and accelerate growth by ensuring the supply of medicinal therapies for the people living in the EU and beyond
  • Sanofi’s Ankleshwar manufacturing facility was established in 1987 having chemistry & biotechnology development center, manufacturers both intermediates and pharmaceutical formulations including tablets

Click here to­ read full press release/ article | Ref: Zentiva | Image: IntelliNews

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post